Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Interest Coverage Ratio (2016 - 2025)

Viridian Therapeutics, Inc.\DE (VRDN) has 12 years of Interest Coverage Ratio data on record, last reported at 37.4 in Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 99.62% year-over-year to 37.4; the TTM value through Dec 2025 reached 73.44, up 57.71%, while the annual FY2025 figure was 73.44, 46.04% up from the prior year.
  • Interest Coverage Ratio reached 37.4 in Q4 2025 per VRDN's latest filing, up from 70.69 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 37.4 in Q4 2025 and bottomed at 9719.11 in Q4 2024.
  • Average Interest Coverage Ratio over 5 years is 1374.3, with a median of 180.16 recorded in 2022.
  • Peak YoY movement for Interest Coverage Ratio: tumbled 5338.94% in 2024, then skyrocketed 99.62% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 9693.67 in 2021, then skyrocketed by 96.99% to 292.06 in 2022, then soared by 38.82% to 178.7 in 2023, then crashed by 5338.94% to 9719.11 in 2024, then skyrocketed by 99.62% to 37.4 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 37.4 in Q4 2025, 70.69 in Q3 2025, and 207.72 in Q2 2025.